Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

Motivational Interviewing to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1
Motivational Interviewing (MI) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse
Status: Enrolling
Updated:  1/11/2017
Willamette Family Treatment Services
mi
from
Eugene, OR
Motivational Interviewing to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1
Motivational Interviewing (MI) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse
Status: Enrolling
Updated: 1/11/2017
Willamette Family Treatment Services
mi
from
Eugene, OR
Click here to add this to my saved trials
Motivational Interviewing to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1
Motivational Interviewing (MI) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse
Status: Enrolling
Updated:  1/11/2017
Changepoint - Cedar Hills Blvd
mi
from
Portland, OR
Motivational Interviewing to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1
Motivational Interviewing (MI) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse
Status: Enrolling
Updated: 1/11/2017
Changepoint - Cedar Hills Blvd
mi
from
Portland, OR
Click here to add this to my saved trials
Motivational Interviewing to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1
Motivational Interviewing (MI) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse
Status: Enrolling
Updated:  1/11/2017
ADAPT
mi
from
Roseburg, OR
Motivational Interviewing to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1
Motivational Interviewing (MI) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse
Status: Enrolling
Updated: 1/11/2017
ADAPT
mi
from
Roseburg, OR
Click here to add this to my saved trials
Motivational Interviewing to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1
Motivational Interviewing (MI) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse
Status: Enrolling
Updated:  1/11/2017
Chesterfield County CSB- Substance Abuse Services
mi
from
Chesterfield, VA
Motivational Interviewing to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1
Motivational Interviewing (MI) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse
Status: Enrolling
Updated: 1/11/2017
Chesterfield County CSB- Substance Abuse Services
mi
from
Chesterfield, VA
Click here to add this to my saved trials
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics - 1
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics
Status: Enrolling
Updated:  1/11/2017
MATRIX/LA Addictions Research
mi
from
Los Angeles, CA
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics - 1
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics
Status: Enrolling
Updated: 1/11/2017
MATRIX/LA Addictions Research
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics - 1
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics
Status: Enrolling
Updated:  1/11/2017
Crossroads Managed Care Systems - Alamosa
mi
from
Alamosa, CO
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics - 1
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics
Status: Enrolling
Updated: 1/11/2017
Crossroads Managed Care Systems - Alamosa
mi
from
Alamosa, CO
Click here to add this to my saved trials
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics - 1
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics
Status: Enrolling
Updated:  1/11/2017
Arapahoe/Douglas Mental Health Network
mi
from
Littleton, CO
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics - 1
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics
Status: Enrolling
Updated: 1/11/2017
Arapahoe/Douglas Mental Health Network
mi
from
Littleton, CO
Click here to add this to my saved trials
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics - 1
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics
Status: Enrolling
Updated:  1/11/2017
Crossroads Managed Care Systems - Pueblo
mi
from
Pueblo, CO
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics - 1
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics
Status: Enrolling
Updated: 1/11/2017
Crossroads Managed Care Systems - Pueblo
mi
from
Pueblo, CO
Click here to add this to my saved trials
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics - 1
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics
Status: Enrolling
Updated:  1/11/2017
Crossroads Managed Care Systems - Trinidad
mi
from
Trinidad, CO
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics - 1
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics
Status: Enrolling
Updated: 1/11/2017
Crossroads Managed Care Systems - Trinidad
mi
from
Trinidad, CO
Click here to add this to my saved trials
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics - 1
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics
Status: Enrolling
Updated:  1/11/2017
LMG Programs, Inc.
mi
from
Stamford, CT
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics - 1
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics
Status: Enrolling
Updated: 1/11/2017
LMG Programs, Inc.
mi
from
Stamford, CT
Click here to add this to my saved trials
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics - 1
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics
Status: Enrolling
Updated:  1/11/2017
HARBEL Prevention and Recovery Center
mi
from
Baltimore, MD
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics - 1
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics
Status: Enrolling
Updated: 1/11/2017
HARBEL Prevention and Recovery Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics - 1
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics
Status: Enrolling
Updated:  1/11/2017
Thomas Jefferson Intensive Sub. Abuse TP
mi
from
Philadelphia, PA
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics - 1
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics
Status: Enrolling
Updated: 1/11/2017
Thomas Jefferson Intensive Sub. Abuse TP
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics - 1
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics
Status: Enrolling
Updated:  1/11/2017
The Charleston Center
mi
from
Charleston, SC
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics - 1
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics
Status: Enrolling
Updated: 1/11/2017
The Charleston Center
mi
from
Charleston, SC
Click here to add this to my saved trials
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics - 1
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics
Status: Enrolling
Updated:  1/11/2017
Circle Park Behavioral Health Services - Florence
mi
from
Florence, SC
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics - 1
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics
Status: Enrolling
Updated: 1/11/2017
Circle Park Behavioral Health Services - Florence
mi
from
Florence, SC
Click here to add this to my saved trials
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics - 1
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics
Status: Enrolling
Updated:  1/11/2017
Circle Park Behavioral Health Services - Lake City
mi
from
Florence, SC
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics - 1
Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics
Status: Enrolling
Updated: 1/11/2017
Circle Park Behavioral Health Services - Lake City
mi
from
Florence, SC
Click here to add this to my saved trials
Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics. - 1
Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics
Status: Enrolling
Updated:  1/11/2017
Aegis Medical Systems, Inc.
mi
from
Bakersfield, CA
Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics. - 1
Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics
Status: Enrolling
Updated: 1/11/2017
Aegis Medical Systems, Inc.
mi
from
Bakersfield, CA
Click here to add this to my saved trials
Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics. - 1
Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics
Status: Enrolling
Updated:  1/11/2017
Oasis Clinic
mi
from
Washington,
Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics. - 1
Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics
Status: Enrolling
Updated: 1/11/2017
Oasis Clinic
mi
from
Washington,
Click here to add this to my saved trials
Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics. - 1
Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics
Status: Enrolling
Updated:  1/11/2017
Glenwood Life Counseling Center
mi
from
Baltimore, MD
Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics. - 1
Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics
Status: Enrolling
Updated: 1/11/2017
Glenwood Life Counseling Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics. - 1
Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics
Status: Enrolling
Updated:  1/11/2017
Lower Eastside Service Center (LESC)
mi
from
New York, NY
Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics. - 1
Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics
Status: Enrolling
Updated: 1/11/2017
Lower Eastside Service Center (LESC)
mi
from
New York, NY
Click here to add this to my saved trials
Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics. - 1
Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics
Status: Enrolling
Updated:  1/11/2017
Greenwich House, Inc.
mi
from
New York, NY
Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics. - 1
Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics
Status: Enrolling
Updated: 1/11/2017
Greenwich House, Inc.
mi
from
New York, NY
Click here to add this to my saved trials
Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics. - 1
Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics
Status: Enrolling
Updated:  1/11/2017
ACT
mi
from
Philadelphia, PA
Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics. - 1
Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics
Status: Enrolling
Updated: 1/11/2017
ACT
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics. - 1
Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics
Status: Enrolling
Updated:  1/11/2017
The Charleston Center
mi
from
Charleston, SC
Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics. - 1
Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics
Status: Enrolling
Updated: 1/11/2017
The Charleston Center
mi
from
Charleston, SC
Click here to add this to my saved trials
A Study of Cabergoline for the Treatment of Cocaine Dependence - 1
Phase 2, Double-Blind, Placebo Controlled Trial of Cabergoline for the Treatment of Cocaine Dependence
Status: Enrolling
Updated:  1/11/2017
Torrance Clinic
mi
from
Torrance, CA
A Study of Cabergoline for the Treatment of Cocaine Dependence - 1
Phase 2, Double-Blind, Placebo Controlled Trial of Cabergoline for the Treatment of Cocaine Dependence
Status: Enrolling
Updated: 1/11/2017
Torrance Clinic
mi
from
Torrance, CA
Click here to add this to my saved trials
A Study of Cabergoline for the Treatment of Cocaine Dependence - 1
Phase 2, Double-Blind, Placebo Controlled Trial of Cabergoline for the Treatment of Cocaine Dependence
Status: Enrolling
Updated:  1/11/2017
Medical University of South Carolina
mi
from
Charleston, SC
A Study of Cabergoline for the Treatment of Cocaine Dependence - 1
Phase 2, Double-Blind, Placebo Controlled Trial of Cabergoline for the Treatment of Cocaine Dependence
Status: Enrolling
Updated: 1/11/2017
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Nicotine Patch for Nicotine Dependence in Individuals With Schizophrenia or Schizoaffective Disorder - 1
High-Dose Versus Regular-Dose Nicotine Patch for Nicotine Dependence in Individuals With Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated:  1/11/2017
UMDNJ - Robert Wood Johnson Medical School-2
mi
from
Piscataway, NJ
Nicotine Patch for Nicotine Dependence in Individuals With Schizophrenia or Schizoaffective Disorder - 1
High-Dose Versus Regular-Dose Nicotine Patch for Nicotine Dependence in Individuals With Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated: 1/11/2017
UMDNJ - Robert Wood Johnson Medical School-2
mi
from
Piscataway, NJ
Click here to add this to my saved trials
Nicotine Patch for Nicotine Dependence in Individuals With Schizophrenia or Schizoaffective Disorder - 1
High-Dose Versus Regular-Dose Nicotine Patch for Nicotine Dependence in Individuals With Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated:  1/11/2017
UMDNJ Robert Wood Johnson Medical School
mi
from
Piscataway, NJ
Nicotine Patch for Nicotine Dependence in Individuals With Schizophrenia or Schizoaffective Disorder - 1
High-Dose Versus Regular-Dose Nicotine Patch for Nicotine Dependence in Individuals With Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated: 1/11/2017
UMDNJ Robert Wood Johnson Medical School
mi
from
Piscataway, NJ
Click here to add this to my saved trials
Telephone Enhancement Procedure for Continuing Care - 1
Telephone Enhancement Procedure (TELE) for Continuing Care
Status: Enrolling
Updated:  1/11/2017
James Gilmore Jr. Treatment Center
mi
from
Kalamazoo, MI
Telephone Enhancement Procedure for Continuing Care - 1
Telephone Enhancement Procedure (TELE) for Continuing Care
Status: Enrolling
Updated: 1/11/2017
James Gilmore Jr. Treatment Center
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Telephone Enhancement Procedure for Continuing Care - 1
Telephone Enhancement Procedure (TELE) for Continuing Care
Status: Enrolling
Updated:  1/11/2017
Julian F. Keith
mi
from
Black Mountain, NC
Telephone Enhancement Procedure for Continuing Care - 1
Telephone Enhancement Procedure (TELE) for Continuing Care
Status: Enrolling
Updated: 1/11/2017
Julian F. Keith
mi
from
Black Mountain, NC
Click here to add this to my saved trials
Telephone Enhancement Procedure for Continuing Care - 1
Telephone Enhancement Procedure (TELE) for Continuing Care
Status: Enrolling
Updated:  1/11/2017
Walter B. Jones, ADATC
mi
from
Greenville, NC
Telephone Enhancement Procedure for Continuing Care - 1
Telephone Enhancement Procedure (TELE) for Continuing Care
Status: Enrolling
Updated: 1/11/2017
Walter B. Jones, ADATC
mi
from
Greenville, NC
Click here to add this to my saved trials
Telephone Enhancement Procedure for Continuing Care - 1
Telephone Enhancement Procedure (TELE) for Continuing Care
Status: Enrolling
Updated:  1/11/2017
Morris Village Alcohol and Drug Treatment Center
mi
from
Columbia, SC
Telephone Enhancement Procedure for Continuing Care - 1
Telephone Enhancement Procedure (TELE) for Continuing Care
Status: Enrolling
Updated: 1/11/2017
Morris Village Alcohol and Drug Treatment Center
mi
from
Columbia, SC
Click here to add this to my saved trials
Assessment of Potential Interactions Between Cocaine and RPR 102681 - 1
Potential Interactions Between IV Cocaine and RPR 102681
Status: Enrolling
Updated:  1/11/2017
Uniformed Services University of Health Science
mi
from
Bethesda, MD
Assessment of Potential Interactions Between Cocaine and RPR 102681 - 1
Potential Interactions Between IV Cocaine and RPR 102681
Status: Enrolling
Updated: 1/11/2017
Uniformed Services University of Health Science
mi
from
Bethesda, MD
Click here to add this to my saved trials
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated:  1/11/2017
GSK Investigational Site
mi
from
Hamden, CT
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated: 1/11/2017
GSK Investigational Site
mi
from
Hamden, CT
Click here to add this to my saved trials
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated:  1/11/2017
GSK Investigational Site
mi
from
Newark, DE
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated: 1/11/2017
GSK Investigational Site
mi
from
Newark, DE
Click here to add this to my saved trials
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated:  1/11/2017
GSK Investigational Site
mi
from
Wilmington, DE
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated: 1/11/2017
GSK Investigational Site
mi
from
Wilmington, DE
Click here to add this to my saved trials
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated:  1/11/2017
GSK Investigational Site
mi
from
Washington,
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated: 1/11/2017
GSK Investigational Site
mi
from
Washington,
Click here to add this to my saved trials
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated:  1/11/2017
GSK Investigational Site
mi
from
Boise, ID
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated: 1/11/2017
GSK Investigational Site
mi
from
Boise, ID
Click here to add this to my saved trials
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated:  1/11/2017
GSK Investigational Site
mi
from
Edwardsville, IL
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated: 1/11/2017
GSK Investigational Site
mi
from
Edwardsville, IL
Click here to add this to my saved trials
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated:  1/11/2017
GSK Investigational Site
mi
from
Hoffman Estates, IL
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated: 1/11/2017
GSK Investigational Site
mi
from
Hoffman Estates, IL
Click here to add this to my saved trials
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated:  1/11/2017
GSK Investigational Site
mi
from
Northfield, IL
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated: 1/11/2017
GSK Investigational Site
mi
from
Northfield, IL
Click here to add this to my saved trials
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated:  1/11/2017
GSK Investigational Site
mi
from
Oak Brook, IL
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated: 1/11/2017
GSK Investigational Site
mi
from
Oak Brook, IL
Click here to add this to my saved trials
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated:  1/11/2017
GSK Investigational Site
mi
from
Oakbrook Terrace, IL
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated: 1/11/2017
GSK Investigational Site
mi
from
Oakbrook Terrace, IL
Click here to add this to my saved trials
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated:  1/11/2017
GSK Investigational Site
mi
from
Cedar Rapids, IA
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated: 1/11/2017
GSK Investigational Site
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated:  1/11/2017
GSK Investigational Site
mi
from
Overland Park, KA
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated: 1/11/2017
GSK Investigational Site
mi
from
Overland Park, KA
Click here to add this to my saved trials
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated:  1/11/2017
GSK Investigational Site
mi
from
Baltimore, MD
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated: 1/11/2017
GSK Investigational Site
mi
from
Baltimore, MD
Click here to add this to my saved trials
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated:  1/11/2017
GSK Investigational Site
mi
from
Rockville, MD
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated: 1/11/2017
GSK Investigational Site
mi
from
Rockville, MD
Click here to add this to my saved trials
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated:  1/11/2017
GSK Investigational Site
mi
from
Belmont, MA
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated: 1/11/2017
GSK Investigational Site
mi
from
Belmont, MA
Click here to add this to my saved trials
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated:  1/11/2017
GSK Investigational Site
mi
from
Farmington Hills, MI
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated: 1/11/2017
GSK Investigational Site
mi
from
Farmington Hills, MI
Click here to add this to my saved trials
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated:  1/11/2017
GSK Investigational Site
mi
from
Minneapolis, MN
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated: 1/11/2017
GSK Investigational Site
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated:  1/11/2017
GSK Investigational Site
mi
from
St. Louis, MO
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated: 1/11/2017
GSK Investigational Site
mi
from
St. Louis, MO
Click here to add this to my saved trials
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated:  1/11/2017
GSK Investigational Site
mi
from
Omaha, NE
Seasonal Affective Depression (SAD) Study
A 7 Month, Multicenter, Parallel, Double-Blind, Placebo-Controlled Comparison of 150-300 mg/Day of Extended-Release Bupropion Hydrochloride and Placebo for the Prevention of Seasonal Depressive Episodes in Subjects With a History of Seasonal Affective Disorder Followed by an 8-week Observational Follow-up
Status: Enrolling
Updated: 1/11/2017
GSK Investigational Site
mi
from
Omaha, NE
Click here to add this to my saved trials